melatonin when given to organophosphate compound poisoning patients at a dose of 3 mg orally reduces the prevalence and duration of delirium .
hence , this study was conducted with the primary aim of assessing the effect of melatonin on delirium and recovery profile in opcp patients .
this prospective , randomised , double - blind , placebo - controlled study was conducted between september 2014 and december 2015 .
patients aged between 18 and 50 years , presenting with history and clinical syndrome suggestive of organophosphorus compound poisoning ( opcp ) with low pseudocholinesterase levels ( < 5320
comparison of outcome measures between two groups ( a and b ) comparison of average daily requirement of fentanyl ( a ) , midazolam and atropine ( b ) between groups , fentanyl and midazolam requirement was significantly lower in group m after day ( p < 0.05 ) the mean heart rate was lower in group m compared to group c ; however , it was statistically significant only on days 2 , 6 , 7 , 8 , 9 and 10 .
the overall prevalence of delirium in group m ( 50.85% ) was lower compared to group c ( 84.81% ) ( p < 0.001 ) . there was a significant reduction in the prevalence of delirium in group m after day 3 , compared to day 1 ( p < 0.004 ) .